What are the causes of elevated hemoglobin (Hb) and hematocrit (Hct)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated hemoglobin and hematocrit levels can result from various conditions, including dehydration, polycythemia vera, chronic hypoxic conditions, certain medications, smoking, kidney diseases, and genetic conditions. The most common cause of elevated hemoglobin and hematocrit is dehydration, which concentrates blood components when fluid volume decreases 1. Other significant causes include:

  • Polycythemia vera, a bone marrow disorder causing excessive red blood cell production, which requires medical attention 1
  • Chronic hypoxic conditions such as COPD, sleep apnea, and high-altitude living, where the body produces more red blood cells to compensate for reduced oxygen 1
  • Certain medications like erythropoietin and anabolic steroids, which can artificially increase red blood cell production 1
  • Smoking, which stimulates red blood cell production through carbon monoxide exposure 1
  • Kidney diseases, which can elevate levels through increased erythropoietin production 1
  • Genetic conditions like polycythemia rubra vera, which can cause inherited elevations 1
  • Testosterone-replacement therapy, which can increase hemoglobin levels by 15 to 20 percent 1 It is essential to identify and address the underlying cause of elevated hemoglobin and hematocrit levels, as persistent elevations can increase the risk of blood clots and cardiovascular complications 1. Treatment options may include phlebotomy for polycythemia vera, CPAP for sleep apnea, or simply increasing fluid intake for dehydration. A thorough diagnostic evaluation, including determination of serum EPO and examination of bone marrow histology, is necessary to formulate a working diagnosis of polycythemia vera 1. In cases where the hemoglobin/hematocrit level is higher than the 95th percentile of the normal distribution or accompanied by a PV-related feature, further investigation is warranted 1. Healthcare providers should monitor patients with elevated hemoglobin and hematocrit levels closely, especially in the elderly, as an attendant increase in blood viscosity could aggravate vascular disease 1.

From the Research

Causes of Elevated Hemoglobin (Hb) and Hematocrit (Hct)

  • Primary causes:
    • Myeloproliferative neoplasm known as polycythemia vera 2
    • Neoplastic diseases like polycythemia vera with proliferation of a cell clone 3
    • Primary proliferative polycythemia (PPP) 4
  • Secondary causes:
    • Excess erythropoietin (EPO) 2
    • Decreased plasma volume 2
    • Chronic hypoxemia 3
    • Reactive forms resulting from chronic hypoxemia 3
    • Smoking 4
  • Other causes:
    • Physiologic form of polycythemia in highlanders and athletes training at high altitude 3
    • Erythropoietin and its analogs used as doping substances to induce polycythemia 3
    • Inherited and environmental causes that lead to polycythemia and erythrocytosis 5
    • Relative polycythemia (reduced plasma volume with a normal red cell mass) 4
    • Modifications of the red cell mass and the plasma volume within their normal ranges 4

Diagnostic Considerations

  • Measurement of serum EPO levels can guide toward the etiology of polycythemia 2
  • Search for JAK2 mutations can aid in diagnosis 2, 6
  • Blood volume studies may be necessary to diagnose polycythemia and its cause 4
  • Further diagnostic tests, such as bone marrow biopsy and JAK-2 gene mutation test, may be required to confirm the final diagnosis 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[How I manage polycythemia].

Revue medicale de Liege, 2024

Research

[Polycythemia].

Deutsche medizinische Wochenschrift (1946), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.